Edasalonexent
Edasalonexent (CAT-1004) is an orally administered small molecule inhibitor of NF-κB, developed for research into Duchenne muscular dystrophy (DMD) . It has been investigated in both in vitro models and in vivo preclinical studies to assess its potential to modulate inflammation and disease progression associated with DMD.
Product Specifications
CAS Number
1204317-86-1
Product Name Alternative
Edasalonexent, CAT1004, CAT-1004, CAT 1004, NFkB, NF-kB, NFκB, NF-κB
Field of Research
Signal Transduction
Purity
99.13% (May vary between batches)
Solubility
DMSO:80 mg/mL (163.04 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2.5 mg/mL (5.09 mM)
Smiles
CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC (=O) NCCNC (=O) c1ccccc1O
Molecular Formula
C31H42N2O3
Molecular Weight
490.68
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1319543-01 0.02 mg (E-Coli)
Recombinant Bacillus cereus UPF0229 protein BC_0551 (BC_0551)
Sign In for Pricing
View Details 
MBS1319543-02 0.02 mg (Yeast)
Recombinant Bacillus cereus UPF0229 protein BC_0551 (BC_0551)
Sign In for Pricing
View Details MBS1319543-03 0.1 mg (E-Coli)
Recombinant Bacillus cereus UPF0229 protein BC_0551 (BC_0551)
Sign In for Pricing
View Details MBS1319543-04 0.1 mg (Yeast)
Recombinant Bacillus cereus UPF0229 protein BC_0551 (BC_0551)
Sign In for Pricing
View Details